Business
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 min |
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 min |
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 min |
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min |
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 min |
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 min |
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min |
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min |
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min |
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 min |
March 2026
Bio Spectrum
Forus Health secures CDSCO approval for AI-led Diabetic Retinopathy screening tool
Bengaluru-based medtech firm Forus Health has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for its FH-POISE DRT (Diabetic Retinopathy Tools).
1 min |
March 2026
Bio Spectrum
Leeford Healthcare commits Rs 200 Cr for expansion of ortho & mobility aids division
Punjab-based Leeford Healthcare has announced a strategic investment of Rs 200 crore in the next three years to rapidly scale its Orthopaedic & Mobility Aids division, signalling a major push into India's fast-growing preventive healthcare and rehabilitation market.
1 min |
March 2026
Bio Spectrum
Govt launches first RDI Fund Call, inaugurates unique initiative of Innovation Financing
Dr Jitendra Singh, Minister of State with Independent Charge for Science & Technology, has launched the first Open Call of Technology Development Board (TDB) under the Research, Development and Innovation (RDI) Fund of the Anusandhan National Research Foundation (ANRF).
1 min |
March 2026
Bio Spectrum
Medicines or Margins? India's Drug Pricing Crossroads.
Pharmaceutical pricing in India lies at the crossroads of economics, ethics and public health.
2 min |
March 2026
Bio Spectrum
Budget 2026-27: Life Sciences Hits & Misses
The recently announced Union Budget 2026-27 by Finance Minister Nirmala Sitharaman has been welcomed as a positive step for the sector at a time when India's life sciences industry is scaling new heights amid an ongoing global tariff war.
5 min |
March 2026
Bio Spectrum
Can Precision Oncology Deliver at Scale in India?
India has launched ambitious initiatives, from large-scale genome mapping to disease-specific genetic studies, to advance precision medicine. But with advanced diagnostic tests accessible to only about 5 per cent of the population, the question remains: is the country ready for precision care? Let's find out.
4 min |
March 2026
Bio Spectrum
Health Ministry to reduce regulatory burden and promote ease of doing pharma business
In line with Prime Minister Narendra Modi's directions to reduce regulatory burden and promote ease of doing business, the Union Ministry of Health and Family Welfare has notified significant amendments to the New Drugs and Clinical Trials Rules, 2019.
1 min |
March 2026
Bio Spectrum
Chhattisgarh eyes investments with highincentive policy and dedicated pharma park
Chhattisgarh government is stepping up efforts to position itself as a leading pharmaceutical and biotechnology hub in central India, backed by a high-incentive industrial policy, a dedicated pharma park at Nava Raipur and expanding healthcare and manufacturing infrastructure in the state.
1 min |
March 2026
Bio Spectrum
Designing Better Healthcare: By Women, For Women
Women's health is expected to see more focus in 2026 due to advancements in medical diagnostics, increased health education, and the rising demand for personalised care.
7 min |
March 2026
Bio Spectrum
ASI Telangana partners with Medtronic to train young surgeons
Medtronic, a global leader in medical technology, has signed a Memorandum of Understanding (MoU) with the Telangana State Chapter of the Association of Surgeons of India (ASI) to train residents, postgraduates, and early career surgeons in open and laparoscopy procedures using new-age technologies via collaborative skill-building training programmes.
1 min |
March 2026
Bio Spectrum
Modern Diagnostic & Research Centre concludes IPO, raising Rs 36.89 Cr
Gurugram-based Modern Diagnostic & Research Centre, a leading diagnostic chain, has successfully concluded its Initial Public Offering (IPO), raising Rs 36.89 crore, which received an exceptional response from investors across categories.
1 min |
March 2026
Bio Spectrum
Wipro GE Healthcare unveils Made-in-India, AI-powered breakthrough in MR imaging
Wipro GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator, announced the launch of SIGNA Prime Elite, its latest MR imaging system, at the Indian Radiological and Imaging Association (IRIA) 2026 Annual Conference in Hyderabad.
1 min |
March 2026
Bio Spectrum
India-EU FTA: Redefining the Pharma Growth Equation
On January 27, 2026, after years of negotiations, India and the European Union announced a landmark Free Trade Agreement.
4 min |
March 2026
Bio Spectrum
"Dependence on China for certain raw materials remains a vulnerability"
Jubilant Biosys - a Noida-based Contract Research, Development, and Manufacturing Organisation (CRDMO), a vertical of Jubilant Pharmova - operates across drug discovery services and the CDMO-API business, with a focus on integrated chemistry-led solutions that support programmes from early discovery through scale-up.
5 min |
March 2026
Bio Spectrum
Kapiva launches Rs 50 Cr innovation fund to build future-ready ayurveda ecosystem
Bengaluru-based Kapiva, India's first modern holistic Ayurvedic brand for millennials, has announced the launch of the Kapiva Innovation Fund (KIF), a commitment of up to Rs 50 crore to support research and innovation in Ayurveda.
1 min |
March 2026
Bio Spectrum
BioAsia 2026 Sets a New Benchmark for Global TechBio Collaboration
BioAsia 2026, the 23rd edition of Asia's premier life sciences and health-tech forum, concluded with unprecedented momentum in Hyderabad, firmly establishing the city's stature as a rising global epicentre for pharmaceuticals, biotechnology and TechBio innovation.
5 min |
March 2026
Bio Spectrum
Novo Medi Sciences launches next-gen Varicella Vaccine built on advanced formulation
Mumbai-based Novo Medi Sciences (Novo Group) has announced the launch of NEXIPOX PLUS, the most recent innovation in Varicella vaccine in decades.
1 min |
March 2026
Bio Spectrum
Zydus unveils world's first biosimilar of Nivolumab, 'Tishtha', in India to treat multiple cancers
Ahmedabad-based Zydus Lifesciences has launched the world's first biosimilar of Nivolumab in India under the brand name Tishtha, reinforcing the company's growing capability in advanced biologics and Immuno-Oncology.
1 min |
March 2026
Bio Spectrum
MedGenome expands infectious disease testing portfolio with MetaSeq
Bengaluru-based MedGenome, India's leading genomics-driven diagnostics company, has announced the launch of MetaSeq, an advanced blood test designed to support faster and more comprehensive detection of bloodstream infections (BSI).
1 min |
March 2026
Bio Spectrum
Wysa gets £5.3 M from Wellcome for digital mental health intervention study on adolescent girls in India
Wellcome has awarded £5.3 million to Bengaluru-based Wysa to fund a scale-up study that will adapt a clinically validated digital mental health intervention for adolescent girls living in rural India, a population facing some of the most significant mental health inequalities globally.
1 min |